You have 9 free searches left this month | for more free features.

Epithelial Cell Adhesion Molecule

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Epithelial Cell Adhesion Molecule in Epithelial Ovarian

Recruiting
  • Ovarian Carcinoma
    • Sohag, Egypt
    • +1 more
    Oct 8, 2022

    Advanced Adenocarcinoma Trial (BA3182)

    Not yet recruiting
    • Advanced Adenocarcinoma
    • (no location specified)
    Apr 10, 2023

    Epithelial-Mesenchymal Transition Associated Markers in

    Recruiting
    • Peri-implantitis
      • Karbala, Iraq
        Talib A. Alnajaty
      Apr 14, 2023

      Determination of Blood Tumor Cells

      Completed
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Abnormalities Cell Epithelial
        • Zurich, Switzerland
          University Hospital Zurich
        Jan 9, 2023

        Periodontitis Trial in Minya (RGD Peptide)

        Completed
        • Periodontitis
        • RGD Peptide
        • Minya, Egypt
        • +1 more
        Dec 7, 2022

        Intrauterine Adhesion Trial in Hangzhou (hAESCs)

        Recruiting
        • Intrauterine Adhesion
        • hAESCs
        • Hangzhou, Zhejiang, China
          Second Affiliated Hospital, School of Medicine, Zhejiang Univers
        Oct 25, 2020

        Epithelial Mesenchymal Transition and Periodontitis

        Recruiting
        • Periodontitis
        • +5 more
        • Modified Widman flap
        • Gingivectomy
        • Baghdad, Iraq
          College of Dentistry, University of Baghdad
        May 30, 2022

        Infiltrating Duct Carcinoma of the Breast

        Not yet recruiting
        • Invasive Breast Cancer
          • (no location specified)
          Jan 28, 2023

          Obesity, Abdominal Obesity, Metabolic Syndrome Trial in Surabaya (Nur Aisiyah Widjaja)

          Completed
          • Obesity
          • +6 more
          • Nur Aisiyah Widjaja
          • Surabaya, East Java, Indonesia
            Institute of Tropical Disease (ITD) Airlangga University, Campus
          Jan 6, 2023

          Inflammation, Vaccine, Intestinal Permeability Trial in Davis (Inulin, Maltodextrin, Ty21a Typhoid Fever Vaccine)

          Recruiting
          • Inflammation
          • +3 more
          • Inulin
          • +2 more
          • Davis, California
            USDA, ARS, Western Human Nutrition Research Center
          Nov 29, 2022

          Airway Remodeling and Rhinovirus in Asthmatics

          Recruiting
          • Asthma
          • Respiratory Disease
          • HRV-39
          • Calgary, Alberta, Canada
            University of Calgary
          Mar 7, 2023

          Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

          Completed
          • Prostate Cancer
          • Madison, Wisconsin
            University of Wisconsin Carbone Cancer Center
          Sep 12, 2022

          Hiatal Hernia and Pulmonary Involvement

          Active, not recruiting
          • Hiatal Hernia
          • Interstitial Lung Disease
          • Blood Collection
          • Bronchoscopy
          • Charlottesville, Virginia
            University of Virginia
          Jan 27, 2023

          Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

          Recruiting
          • Urinary Bladder Neoplasms
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

          Recruiting
          • Clinical Stage 0 Cutaneous Melanoma AJCC v8
          • +43 more
          • Best Practice
          • +7 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 12, 2022

          Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)

          Recruiting
          • Epithelial Ovarian Cancer
          • +2 more
          • ITIL-306
          • Saint Louis, Missouri
          • +1 more
          Aug 15, 2022

          Non-Muscle Invasive Bladder Cancer Trial in Shanghai (VB4-845 Injection)

          Recruiting
          • Non-Muscle Invasive Bladder Cancer
          • VB4-845 Injection
          • Shanghai, China
            Fudan University Shanghai Cancer Center
          Apr 21, 2021

          SOX17 and E-Cadherin in Variable Endometrial Lesions

          Not yet recruiting
          • Variable Endometrial Lesions
            • Sohag, Egypt
              Sohag faculty of Medicine
            Nov 9, 2023

            Vitiligo Trial in Cairo (Narrow band UVB)

            Active, not recruiting
            • Vitiligo
            • Narrow band UVB
            • Cairo, El Manial, Egypt
              Kasr El Ainy university hospital, Faulty of medicine,Cairo unive
            Mar 10, 2022

            NSCLC Trial in United States (erlotinib, bemcentinib)

            Completed
            • Non-Small Cell Lung Cancer
            • Los Angeles, California
            • +9 more
            Aug 16, 2022

            Tumors Trial in Beijing ([68Ga]N188)

            Recruiting
            • Neoplasms
            • Beijing, Beijing, China
              Peking University First Hospital
            Jan 27, 2023

            Colorectal Cancer Trial (Characterization of tumor tissue by fluorescence)

            Withdrawn
            • Colorectal Cancer
            • Characterization of tumor tissue by fluorescence
            • (no location specified)
            Mar 28, 2022

            Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

            Active, not recruiting
            • Colorectal Cancer
            • Los Angeles, California
            • +12 more
            Aug 19, 2022

            Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

            Recruiting
            • Renal Cell Carcinoma
            • +4 more
            • Shanghai, Shanghai, China
              Huadong Hospital Affiliated to Fudan University
            Jun 30, 2022

            Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

            Recruiting
            • Extranodal NK T Cell Lymphoma
            • NK-Cell Leukemia
            • Anti-CD56 CAR T
            • Xuzhou, Jiangsu, China
              The Affiliated Hospital of Xuzhou Medical University
            Jul 10, 2023